SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017861
Filing Date
2023-11-07
Accepted
2023-11-07 07:40:39
Documents
96
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-20230930x10q.htm   iXBRL 10-Q 2558027
2 EX-31.1 xoma-20230930xex31d1.htm EX-31.1 10616
3 EX-31.2 xoma-20230930xex31d2.htm EX-31.2 10618
4 EX-32.1 xoma-20230930xex32d1.htm EX-32.1 8739
  Complete submission text file 0001558370-23-017861.txt   11177206

Data Files

Seq Description Document Type Size
5 EX-101.SCH xoma-20230930.xsd EX-101.SCH 93871
6 EX-101.CAL xoma-20230930_cal.xml EX-101.CAL 47610
7 EX-101.DEF xoma-20230930_def.xml EX-101.DEF 491169
8 EX-101.LAB xoma-20230930_lab.xml EX-101.LAB 676038
9 EX-101.PRE xoma-20230930_pre.xml EX-101.PRE 664574
90 EXTRACTED XBRL INSTANCE DOCUMENT xoma-20230930x10q_htm.xml XML 1912651
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 231381607
SIC: 2834 Pharmaceutical Preparations